Skip to content

Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer

Nurse-led Colon Cancer Risk Counseling for First-degree Relatives to Enhance Use of Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01903395
Acronym
FAMKOL
Enrollment
313
Registered
2013-07-19
Start date
2012-03-31
Completion date
2015-12-31
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Keywords

Colorectal Neoplasms/*drug therapy/*secondary, Health Services Accessibility, Humans, Supportive Care Needs, Psychooncology, Primary Health Care/*methods, Treatment Outcome, Socioeconomic Factors, Quality Assurance, Health Care, Adult, Aged, Aged, 80 and over

Brief summary

BACKGROUND: First-degree relatives of patients with colorectal cancer are at increased risk for colorectal cancer as well. Nevertheless, participation in the German national screening program stagnates at 2-3 percent per year even in this high-risk population. AIM: The study is aimed to increase the portion of the first-degree relatives on 50% which take up a preventive colonoscopy. METHODS: Cluster-randomized controlled multi-center trial. Study sites (clusters) are mainly certified cancer centers and office-based gastroenterologists from all over Germany. Index-patients with colorectal cancer of different stages are asked to hand over the study material to their relatives, consisting of an invitation to a nurse-led counseling on preventive colonoscopy and an one-to-one appointment with a clinical expert of one of the study sites next.

Interventions

BEHAVIORALNurse-led counselling

Nurse-led telephone counselling to double the utilization of preventive colonoscopy

Sponsors

Martin-Luther-Universität Halle-Wittenberg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* aged 18 and over * being first-degree relatives of patients with diagnosed colorectal cancer * able to understand German

Exclusion criteria

* Familial Adenomatous Polyposis * utilization of diagnostic colonoscopy within the past 5 years * being ever treated for colorectal cancer * actual inflammatory bowl disease * comorbidities associated with reduced further life expectancy (ECOG performance status \>3

Design outcomes

Primary

MeasureTime frame
utilization of preventive colonoscopyutilization within 30 days after enrolement

Secondary

MeasureTime frameDescription
Rate of advanced adenomas or carcinomas in situRate within 6 month after enrolement
post-operative complications associated with the colonoscopywithin 30 days after enrolement
barriers to the use of preventive colonoscopywithin 30 day after enrolement, additional at 6 months after enrolementBarriers against preventive colonoscopy are very common among the healthy population. Such barriers can bei either of cognitive (e.g. being afraid of the potential diagnosis) or emotional nature (e.g. shame to be exposed naked to the examiners). Barriers are assessed by Barriers Questionnaire-II (BQ-II) during telephone counselling.
effectiveness and cost-effectiveness of nurse-led counsellingwithin 30 days after enrolement
time delay between signed informed consent and utilization of colonoscopyat utilization of the colonoscopy

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026